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Inspiratory Effort and Lung Mechanics in
Spontaneously Breathing Patients with Acute
Respiratory Failure due to COVID-19: A Matched
Control Study
To the Editor:
A great debate has started as to whether acute respiratory failure
(ARF) induced by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection (coronavirus disease [COVID-19]) should
be classified as a classic form of acute respiratory distress syndrome
(ARDS) or a subtype of lung injury with different pathophysiological
characteristics (1) and mechanisms of progression (2). The
magnitude of inspiratory effort correlated with the need to switch to
invasive ventilation in patients without COVID-19 suggest that self-
inflicted lung injury could play a role (3).
We aimed to describe and compare the inspiratory effort
(primary outcome) and the breathing pattern of spontaneously
breathing patients with ARF due to COVID-19 and historically
matched patients without COVID-19, either type a candidate for
noninvasive mechanical ventilation (NIV).
Patients with COVID-19 were treated at the Respiratory Intensive
Care Unit and the Intensive Care Unit of the University Hospital of
Modena (fromAugust 1, 2020, toMarch 15, 2021) and 1:1 propensity
matched (by PaO2/FIO2 ratio, age, bodymass index, and Sequential
Organ Failure Assessment score) with non–COVID-19 patients
extracted from our dataset (period 2016 to 2021). The logit of the score
was taken with a caliper of 0.2 to maximize the number of patients
without compromising the match. All patients were in a similar phase
from onset of ARF, unable to maintain SaO2. 92% despite optimized
high-flow oxygen, and thus were candidates to receive NIV according
to local protocol. The study was conducted in accordance with the
local “AVEN Ethics Committee” approval (protocol 4485/CE) and
represents a report of ancillary data of a registered protocol (www.
clinicaltrials.gov [NCT03826797]).
On admission, demographics, clinical characteristics and
severity, respiratory function, and peripheral blood lactate and
D-dimer concentrations were recorded.
A nasogastric tube with pressure transducer and monitoring
system (NutriVent and OptiVentTM, SIDAM,Mirandola-I) to
record swings in esophageal pressure (Pes) and dynamic
transpulmonary pressure (PL) was placed as previously described (3).
For recording, we always referred to DPes and DPL from the
end-expiratory level, calculated as recommended (4). Expiratory tidal
volume (VTE) was obtained by numerical integration of the flow
signal and adjusted to the predicted body weight (in kilograms).
The VTE/DPL ratio was measured as a surrogate for lung compliance
(“dynamic compliance”). A simplified surrogate of mechanical power
(“dynamic mechanical power”) was calculated as 0.0983RR
3VTE3 (DPL1 positive end-expiratory pressure), where RR
represents respiratory rate (5).
Measures were recorded for patients of both groups under
standardized conditions with unassisted breathing (5 min long) and
then 2 hours after starting NIV (Engstr€omCarestation [GE
Healthcare]). Pressure support was started at 10 cmH2O and then
adjusted according to Carteaux and colleagues (6) to target a
peripheral oxygen saturation as measured by pulse oximetry.92%
with a delivered FIO2, 0.7. Endotracheal intubation rate and 28-day
death rate were recorded.
The Student’s t test assessed the between-group difference when
data were distributed normally; otherwise, the Mann-WhitneyU test
was used. A comparison between dichotomous variables was
performed with the x2 test or Fisher exact test. ANOVAwas used to
test as an interaction for whether the change in physiological variables
2 hours after NIV was different between groups.
Table 1 shows the characteristics of patients at admission and the
clinical outcomes. Compared with the non–COVID-19 group,
patients with COVID-19 before NIV showed lower values of
inspiratory effort as assessed byDPes (Figure 1). Shown are baseline
values of lung mechanics, RR, V_ E, VTE, and dynamic mechanical
power at baseline and 2 hours after NIV are resumed (Table 1). The
COVID-19 group showed lower values of RR (P, 0.001), VTE
(P=0.003), V_ E (P, 0.001), and dynamic mechanical power
(P, 0.001) and higher dynamic compliance (P, 0.001) compared
with the non–COVID-19 group. After NIV, a reduction inDPes and
RR and an increase in dynamicmechanical power was reported for
both groups, whereas no change was noted in either dynamic
compliance or VTE. Despite there being no group interactions or
changes in the physiological variables after NIV,DPL showed a
significant increase in the COVID-19 group. In this group, the baseline
value of dynamic mechanical power was considerably lower than in
the non–COVID-19 group (27 vs. 95 J/min, P, 0.0001) and
was significantly increased following NIV. This may suggest an
unfavorable interaction between kinetic energy transferred from the
respiratory muscles and the NIV to the lungs of these patients,
at least early. Nevertheless, the absolute value of dynamic
mechanical power was lower in patients with COVID-19 than in
non–COVID-19 patients.
To our knowledge, this is the first report assessing inspiratory
effort and respiratory mechanics in spontaneously breathing patients
with COVID-19 developing ARF. At their early onset of ARF, these
patients showed different mechanical characteristics and breathing
patterns when compared with non–COVID-19 patients.
It has been speculated that the progression across COVID-19may
be triggered by excessive inspiratory drive activation (7).We have
previously found that patients withmoderate to severe ARDS exhibited
very high inspiratory effort—even early during NIV—which was
associated with unfavorable outcomes (3). Because themean arterial
pHwas 7.48 in both groups, patients with COVID-19 also appeared to
have a (relatively) high respiratory drive. However, the inspiratory
effort of patients with COVID-19 was lower than in non–COVID-19
patients, thus suggesting amismatch between lungmechanics and
hypoxia, at variance with the typical form of ARDS. Indeed, a different
lungmorphology, as compared with ARDS, might explain this: the
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higher presence of areas with a low V_ /Q_ ratio (i.e., ground
glass=poorly aerated tissue with higher compliance) as compared with
true shunted areas (atelectasis=consolidations with lower compliance)
may be the basis of these findings. This study showed that, when
spontaneous breathing is preserved, the dynamic compliance of the
respiratory system is twice as high in patients with COVID-19
compared with thematched non–COVID-19 patients; furthermore, the
abnormally elevatedmeanD-dimer value found in patients with
COVID-19 (Table 1) suggests microvasculature involvement in the
mechanism of ARF.
Nevertheless, previous reports (8, 9) led to the recommendation
of similar ventilatory strategies in patients with hypoxemic ARF,
without any regard as to whether they follow COVID-19 or
non–COVID-19 underlying conditions (10). At least in the early
phase of ARF, the magnitude of inspiratory effort in patients with
COVID-19 is lower than in non–COVID-19, probably limiting the
likely significance of self-inflicted lung injury. Indeed, a simple
surrogate marker of mechanical power was considerably lower in
patients with COVID-19. Although the application of NIV resulted in
a significant reduction of inspiratory effort and RR (Table 1),DPL
increased, thus calling into question the optimal time to start
ventilation.
Our study suffers from several limitations. First, it represents an
exploratory analysis with no sample size assessment, a limited
number of patients, and a monocentric design. Second, the higher
baseline blood lactate value in the non–COVID-19 group may reflect
a difference in terms of balance from oxygen delivery to tissue
metabolic needs, with a potential influence on the breathing pattern.
An elevated value of lactic anions as a nonmechanical factor, even in
the absence of blood acidosis, might have boosted the ventilatory
response, influencing the different behavior between groups. Third,
the observational nature of the study design does not allow us to draw
firm conclusions about respiratory response to NIV application.
Nevertheless, we believe that this preliminary observation supports
the implementation of continuous monitoring of the patient’s
inspiratory effort during episodes of hypoxemic ARF. In contrast
with non–COVID-19 patients, the findings indicate a limited
inspiratory effort in the early phase of ARF in patients with
Table 1. Characteristics of the Study Groups at Inclusion, Ventilatory Settings, and Clinical Outcome and Mechanical Variables
before and after NIV
Clinical Variables COVID-19 (n=30) Non–COVID-19 (n=30) P Value
Age, yr 68 (57–77) 68 (57–78) 0.9
Sex, M 23 (77) 22 (73) 0.9
BMI, kg/m2 24 (21–27) 24 (20–26) 0.9
Charlson index score 3 (2–4) 4 (2–5) 0.1
Kelly scale score 1 (1–1) 1 (1–1) 0.9
SOFA score 3 (3–4) 3 (3–4) 0.9
PaO2/FIO2, mm Hg* 127 (100–138) 124 (100–133) 0.9
PaO2/FIO2 2 h after NIV, mm Hg 133 (118–155) 139 (119–158) 0.4
pH 7.48 (7.46–7.5) 7.48 (7.44–7.5) 0.7
pH after NIV 7.45 (7.44–7.46) 7.46 (7.43–7.48) 0.5
PaCO2, mm Hg 33 (30–38) 34 (30–40) 0.7
PaCO2 after NIV 35 (32–37) 35 (32–36) 0.7
Blood lactate, mmol/L 1 (0.7–1.2) 1.7 (1–2.2) 0.001
Serum creatinine, mg/dl 0.7 (0.6–0.9) 0.7 (0.5–0.9) 0.8
D-dimer, mg/dl 1,310 (862–9,400) 815 (540–1,233) 0.01
PEEP, cm H2O
† 10 (8–10) 10 (8–11) 0.7
PSV, cm H2O
† 12 (10–12) 12 (10–16) 0.2
ETI 9 (30) 11 (37) 0.8




after NIV P Value Baseline
2 Hours
after NIV P Value
Interaction
Test (ANOVA)
DPes, cm H2O 12.5 (11.8–17.3) 7.6 (6–10) ,0.0001 32 (25–38) 18 (12–34) ,0.0001 0.1
DPL, cm H2O 12.5 (11.8–17.3) 18.4 (16.9–21.3) ,0.0001 32 (25–38) 32 (26–43) 0.1 0.1
RR, breaths/min 28 (25–30) 24 (21–26) ,0.0001 35 (30–41) 31 (24–38) 0.02 0.1
V_ E, L/min 20 (17–23) 18 (15–22) 0.1 27 (23–32) 24 (20–28) 0.004 0.6
VTE, ml/kg of PBW 9.2 (8.1–10.3) 10.1 (8.7–11.2) 0.3 10.9 (9.3–12) 10.2 (9.9–12) 0.8 0.6
Dynamic compliance, ml/cm H2O 55 (40–69) 41 (31–52) 0.1 25 (19–31) 21 (16–34) 0.7 0.2
Dynamic mechanical power, J/min 27 (19–40) 56 (41–60) ,0.0001 95 (68–107) 102 (66–130) 0.1 0.2
Definition of abbreviations: BMI=body mass index; COVD-19=coronavirus disease; ETI =endotracheal intubation; IQR= interquartile range;
NIV=noninvasive mechanical ventilation; PBW=predicted body weight; PEEP=positive end-expiratory pressure; Pes=esophageal pressure;
PL =dynamic transpulmonary pressure; PSV=pressure support value; RR= respiratory rate; SOFA=Sequential Organ Failure Assessment;
VTE = expiratory tidal volume.
Data are presented as number (percentage) for dichotomous values or median (IQR) for continuous values.
*The values of the PaO2/FIO2 ratio used for matching these groups as well as pH and PCO2 values were those measured during high-flow nasal
oxygen (see inclusion criteria earlier) immediately before starting NIV.
†PEEP and PSV values reported were those measured during the first 2 hours of NIV.
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COVID-19, thus suggesting that caution should be taken when
considering early endotracheal intubation to anticipate protective
mechanical ventilation in these individuals.
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Figure 1. Measured individual values of change in esophageal pressure (DPes) and change in dynamic transpulmonary pressure (DPL) in the
matched study groups at baseline and 2 hours after initiating noninvasive mechanical ventilation (NIV). No statistical difference was found
when testing as an interaction for whether the change of DPes and DPL 2 hours after starting NIV was different between coronavirus disease
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Rodin’s Thinker: An Alternative Position in Awake
Patients with COVID-19
To the Editor:
Prone positioning is indicated in invasively ventilated patients with
acute respiratory distress syndrome and coronavirus disease
(COVID-19) (1, 2). It improves _V/ _Q matching and oxygenation
while allowing for greater lung protection (3)
Because of the high influx of patients, heavily burdening
ICU capacities during the COVID-19 pandemic, clinicians
worldwide have sought strategies to avoid invasive ventilation.
The use of prone positioning in awake, nonintubated,
spontaneously breathing patients (possibly combined with
noninvasive respiratory support) has been investigated by
several groups. Awake prone positioning is a feasible strategy
and is well tolerated by most patients, with a clear benefit to
oxygenation, although the effect on outcome is still unclear (4–6).
However, a significant number of patients, ranging between
8.9% and 63.3%, are unable to tolerate this position (4–6). Moreover,
a recent study investigating the use of a patient-directed prone
positioning protocol was stopped early owing to poor protocol
adherence (7).
In a context characterized by a lack of resources, we
therefore sought an alternative strategy that would retain the
pathophysiological benefits of prone positioning in awake
patients while being more tolerable. We began to invite patients
to lie chest forward on a flat surface while sitting (Figure 1). This
position is reminiscent of the famous sculpture “The Thinker” by
Auguste Rodin (1840–1917) (Figure 1A), and we therefore
named it “Rodin’s position,” although it is better known as
“tripod position” (8).
Methods
Patient population. We retrospectively reviewed the records of
patients admitted to respiratory high-dependency units at San
Gerardo Hospital (Monza, MB, Italy) between November 1, 2020,
and January 15, 2021, during the second COVID-19 wave. The local
protocol was to place all patients with COVID-19 acute respiratory
distress syndrome in Rodin’s position for at least 3 hours daily. Data
were collected in a local online registry as part of the STORM study
(Spallanzani Institute approval number 84/2020; NCT04424992),
which did not include the present evaluation as a prespecified
endpoint. Patients’ consent was waived. Patients were enrolled if they
were receiving noninvasive respiratory support and had undergone at
least 3 hours in Rodin’s position. Lack of a complete set of arterial
blood gases within a specified time range (seewhat follows) was the
only exclusion criterion.
Study protocol. Patients were invited to sit on a chair and rest
their chest on a flat, elevated surface (i.e., their bed or a desk, at
intermammillary line), thus placing the chest in a “semiprone”
position (Figures 1B and 1C). The head was laid on the arms, elevated
and crossed. Respiratory support variables (interface, FIO2, and
positive end-expiratory pressure [PEEP]) were left unchanged
between the different time points.
We collected data on patient age; medical history C-reactive
protein; platelet count; D-dimer; ventilation interface and
parameters (FIO2 and PEEP); arterial blood gas and respiratory rate
in semisupine position before Rodin’s position (supinePRE), while
in Rodin’s position, and in semisupine position after Rodin’s
position (supinePOST); incidence of intubation; and death. Data were
considered only in a window of 3 hours before supinePRE and after
supinePOST.
Statistical analysis. Data are described as number (percentage)
for categorical variables and as mean6 SD or median (interquartile
range) for continuous variables, depending on their distribution.
Normality was assessed using the Shapiro-Wilk test. A one-way
ANOVA for repeated measures was performed to compare arterial
blood gas values and respiratory rates at the three different
time points.
Results
During the study period, 147 patients were admitted to the
respiratory high-dependency units at San Gerardo Hospital. Of these,
37 patients did not undergo Rodin’s position—it was not indicated by
clinicians for 34 patients (26 patients too mild, 4 bleeding risk, and 4
admitted for palliation), and it was not tolerated by 3 patients (2 had
psychiatric disorders, and 1 had dementia). A total of 110 patients
underwent at least one cycle of Rodin’s position; 85 were excluded
from the study (no arterial blood gas at all specified time points), and
a total of 25 patients were included in the present analysis.
Most patients were male, aged 65.06 8.6 years; about half (44%)
had hypertension, 12% had diabetes, and 12.0% had a malignancy.
All patients were receiving continuous positive airway pressure by
helmet, with an FIO2 of 60 (50–77.5), a PEEP of 10 cmH2O (8–10),
and a baseline PaO2/FIO2 of 146.26 62.7 mmHg. Rodin’s position was
initiated 4.26 3.4 days after hospitalization, and patients underwent
5.46 3.4 cycles. No clinically relevant side effects were reported. Of
these 25 patients, 18 also underwent cycle(s) of prone position (in 9
cases before the first Rodin cycle), but not during the supinePRE-to-
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